2016-03-14T00:00:00.000-04:00
Exchange Commission,0.491151
dividend yield,0.360226
strong buy rating,0.254615
price objective,0.442837
BKD Wealth Advisors,0.339113
recent quarter,0.452808
chief executive officer,0.233623
stock,0.057971
InvestorPlace Broker Center,0.555736
firm’s stock,-0.242774
Somerset Trust,0.401248
biopharmaceutical company,0.461014
personal trading style,0.598412
recent disclosure,0.491151
research-based biopharmaceutical company,0.642682
average rating,-0.247964
research note,0.466375
Gilead Sciences Inc.,0.555178
Neuberger Berman Group,0.452808
average price,0.140575
shares,0.0678121
concise daily summary,0.447788
consensus target price,0.440905
Gilead Sciences,0.19856
stock broker,0.245696
mid-day trading,-0.252324
John C. Martin,-0.211106
Wealth Advisors LLC,0.339113
Berman Group LLC,0.452808
chronic hepatitis,-0.646567
EVP Paul Rutherford,-0.274442
quarter,0.397723
